Esperion Therapeutics Stock In The News

ESPR Stock  USD 1.87  0.06  3.31%   
Our overall analysis of Esperion Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Esperion Therapeutics. The specific impact of Esperion Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Esperion Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Esperion Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Esperion Therapeutics Backtesting and Esperion Therapeutics Hype Analysis.
To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.

Esperion Therapeutics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2025/08/07/3129837/0/en/Esperion-Announces-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
 Bullish
Yahoo News
ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises
https://finance.yahoo.com/news/esprs-q2-earnings-revenues-trump-154200342.html
 Bullish
seekingalpha News
Esperion rises after revenue beat, Q1 profitability expectation
https://seekingalpha.com/news/4478614-esperion-rises-after-revenue-beat-q1-profitability-expectation?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
nasdaq News
Esperion Therapeutics Inc (NASDAQ:ESPR) Beats Q2 2025 Revenue Forecasts and Reduces Losses Amid Strong Prescription Growth
https://www.chartmill.com/news/ESPR/Chartmill-32308-Esperion-Therapeutics-Inc-NASDAQESPR-Beats-Q2-2025-Revenue-Forecasts-and-Reduces-Losses-Amid-Strong-Prescription-Growth
 Bullish
seekingalpha News
Esperion Therapeutics GAAP EPS of -$0.02 beats by $0.13, revenue of $82.39M beats by $19.34M
https://seekingalpha.com/news/4478181-esperion-therapeutics-gaap-eps-of-0_02-beats-by-0_13-revenue-of-82_39m-beats-by-19_34m?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
Macroaxis News: globenewswire.com
Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2025/08/05/3127116/0/en/Esperion-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
 Neutral
seekingalpha News
Here are the major earnings before the open Tuesday
https://seekingalpha.com/news/4477233-here-are-the-major-earnings-before-the-open-tuesday?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral
Yahoo News
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q2 Earnings Expected to Decline
https://finance.yahoo.com/news/earnings-preview-crinetics-pharmaceuticals-inc-140004802.html
 Bullish
Yahoo News
Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat Estimates
https://finance.yahoo.com/news/neurocrine-biosciences-nbix-q2-earnings-211001734.html
 Bullish
Yahoo News
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
https://finance.yahoo.com/news/analysts-estimate-esperion-therapeutics-espr-140004961.html
 Bullish

Esperion Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Esperion and other traded companies coverage with news coverage. We help investors stay connected with Esperion headlines for the 10th of August to make an informed investment decision based on correlating the impacts of news items on Esperion Stock performance. Please note that trading solely based on the Esperion Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Esperion Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Esperion Therapeutics investors visualize upcoming and past events in order to time the market based on Esperion Therapeutics noise-free hype analysis.

Esperion Therapeutics Investors Sentiment

The influence of Esperion Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Esperion. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Esperion Therapeutics' public news can be used to forecast risks associated with an investment in Esperion. The trend in average sentiment can be used to explain how an investor holding Esperion can time the market purely based on public headlines and social activities around Esperion Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Esperion Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Esperion Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Esperion Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Esperion Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Esperion Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Esperion Therapeutics' short interest history, or implied volatility extrapolated from Esperion Therapeutics options trading.

Additional Tools for Esperion Stock Analysis

When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.